Skip to main content

Table 1 Baseline characteristics of the study sample.

From: Feasibility study of a clinically-integrated randomized trial of modifications to radical prostatectomy

  No fascial suturing (n = 77) Fascial suturing (n = 77)
Age 61.1 (57.8, 64.1) 61.3 (57.7, 65.3)
PSA at diagnosis 5.19 (3.66, 6.59) 5.17 (3.76, 6.59)
Clinical stage T1 57 (74%) 52 (68%)
Clinical stage T2a 12 (16%) 14 (18%)
Clinical stage T2b+ 8 (10%) 11 (14%)
Biopsy Gleason grade   
6 28 (36%) 29 (38%)
7 42 (55%) 40 (52%)
8 7 (9%) 8 (10%)
Patients undergoing surgery n = 74 n = 77
Pathologic Gleason grade1   
6 10 (14%) 8 (11%)
7 57 (77%) 59 (79%)
8 7 (9%) 8 (11%)
Positive surgical margins2 11 (15%) 9 (12%)
Seminal vesicle invasion 5 (7%) 7 (9%)
Extraprostatic extension 35 (47%) 36 (48%)
Lymph node invasion 6 (8%) 6 (8%)
  Irrigation (n = 77) No irrigation (n = 77)
Age 60.3 (55.9, 65.2) 59.9 (56.1, 64.2)
PSA at diagnosis 4.95 (3.72, 6.90) 4.95 (3.66, 6.90)
Clinical stage T1 44 (57%) 49 (64%)
Clinical stage T2a 18 (23%) 16 (21%)
Clinical stage T2b+ 15 (19%) 12 (16%)
Biopsy Gleason grade   
6 30 (39%) 29 (38%)
7 32 (42%) 34 (44%)
8 15 (19%) 14 (18%)
Patients undergoing surgery n = 74 n = 76
Pathologic Gleason grade1   
6 9 (12%) 11 (15%)
7 59 (78%) 57 (76%)
8 8 (11%) 7 (9%)
Positive surgical margins2 11 (14%) 13 (17%)
Seminal vesicle invasion 10 (13%) 8 (11%)
Extraprostatic extension 35 (45%) 34 (45%)
Lymph node invasion 7 (9%) 7 (9%)
  1. All values are median (IQR) or frequency (proportion).
  2. 1. Grade not assess in one patient due to neoadjuvant therapy
  3. 2. One patient missing data